Penzberg, Germany

Alexander Bujotzek

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 10.1

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Penzberg, DE (2021 - 2023)
  • Munich, DE (2024)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: The Innovations of Alexander Bujotzek

Introduction

Alexander Bujotzek is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antigen binding molecules and antibodies. With a total of eight patents to his name, Bujotzek's work has the potential to impact various therapeutic applications.

Latest Patents

Among his latest patents is the invention titled "Bispecific antigen binding molecules comprising anti-FAP clone 212." This invention relates to novel bispecific antigen binding molecules that include at least one antigen binding domain capable of specific binding to Fibroblast Activation Protein (FAP) comprising FAP clone 212 or variants thereof, and at least one antigen binding domain capable of specific binding to CD40. The patent also covers methods of producing these molecules and their applications. Another significant patent is for "Anti-HLA-G antibodies and methods of use thereof," which focuses on anti-HLA-G antibodies and their various applications in medical treatments.

Career Highlights

Bujotzek has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Throughout his career, Bujotzek has collaborated with esteemed colleagues such as Christian Klein and Harald Duerr. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Alexander Bujotzek's innovative work in biotechnology, particularly in the realm of bispecific antibodies, showcases his commitment to advancing medical science. His contributions through patents and collaborations highlight the importance of innovation in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…